Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (28)

2022

  1. Associations between frailty trajectories and frailty status and adverse outcomes in community-dwelling older adults

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 13, Núm. 1, pp. 230-239

  2. Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 13, Núm. 2, pp. 884-893

  3. Effects of a 12-week Vivifrail exercise program on intrinsic capacity among frail cognitively impaired community-dwelling older adults: secondary analysis of a multicentre randomised clinical trial

    Age and ageing, Vol. 51, Núm. 12

2021

  1. G Protein-Coupled Estrogen Receptor Immunoreactivity in the Rat Hypothalamus Is Widely Distributed in Neurons, Astrocytes, and Oligodendrocytes, Fluctuates during the Estrous Cycle, and Is Sexually Dimorphic

    Neuroendocrinology, Vol. 111, Núm. 7, pp. 660-677

2020

  1. Physical activity trajectories, mortality, hospitalization, and disability in the Toledo Study of Healthy Aging

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 11, Núm. 4, pp. 1007-1017

2019

  1. Effect of a multicomponent exercise programme (VIVIFRAIL) on functional capacity in frail community elders with cognitive decline: Study protocol for a randomized multicentre control trial

    Trials, Vol. 20, Núm. 1

2014

  1. ApoE gene and exceptional longevity: Insights from three independent cohorts

    Experimental Gerontology, Vol. 53, pp. 16-23

2013

  1. Stress-induced neuroinflammation: Role of the toll-like receptor-4 pathway

    Biological Psychiatry, Vol. 73, Núm. 1, pp. 32-43

2012

  1. Comparative in vitro activity of common antibiotics and relationship with changes in Streptococcus pneumoniae serotypes causing otitis in children prior to and 10 years after introduction of conjugate vaccines in Spain

    International Journal of Antimicrobial Agents

  2. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain

    International Journal of Antimicrobial Agents, Vol. 40, Núm. 1, pp. 18-23

2011

  1. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 5, pp. 2297-2302

  2. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009

    BMC Infectious Diseases, Vol. 11

2010

  1. Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5387-5390

  2. Susceptibility of recently collected spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 6, pp. 2696-2698

2009

  1. Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine

    Journal of Antimicrobial Chemotherapy

2008

  1. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1234-1240

  2. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1430-1433

  3. High protein binding and cidal activity against penicillin-resistant S. pneumoniae: A cefditoren in vitro pharmacodynamic simulation

    PLoS ONE, Vol. 3, Núm. 7

  4. In vitro activity of ME1036 versus other β-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC

    Journal of Antimicrobial Chemotherapy

  5. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime

    Antimicrobial Agents and Chemotherapy